Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial

T. Burkard; C. A. Kaiser; H. Brunner-La Rocca; S. Osswald; M. E. Pfisterer; R. V. Jeger

doi:10.1111/j.1365-2796.2011.02423.x

Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial

T. Burkard, C. A. Kaiser, H. Brunner-La Rocca, S. Osswald, M. E. Pfisterer, R. V. Jeger^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	257-263
Journal	Journal of Internal Medicine
Volume	271
Issue number	3
DOIs	https://doi.org/10.1111/j.1365-2796.2011.02423.x
Publication status	Published - Mar 2012

Keywords

antiplatelet therapy
coronary artery disease
myocardial infarction
percutaneous coronary intervention

Access to Document

10.1111/j.1365-2796.2011.02423.x

Cite this

Burkard, T., Kaiser, C. A., Brunner-La Rocca, H., Osswald, S., Pfisterer, M. E., & Jeger, R. V. (2012). Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial. Journal of Internal Medicine, 271(3), 257-263. https://doi.org/10.1111/j.1365-2796.2011.02423.x

@article{721597e882e2499590220b6e1433b46a,

title = "Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial",

keywords = "antiplatelet therapy, coronary artery disease, myocardial infarction, percutaneous coronary intervention",

author = "T. Burkard and Kaiser, {C. A.} and {Brunner-La Rocca}, H. and S. Osswald and Pfisterer, {M. E.} and Jeger, {R. V.}",

year = "2012",

month = mar,

doi = "10.1111/j.1365-2796.2011.02423.x",

language = "English",

volume = "271",

pages = "257--263",

journal = "Journal of Internal Medicine",

issn = "0954-6820",

publisher = "Wiley",

number = "3",

}

Burkard, T, Kaiser, CA, Brunner-La Rocca, H, Osswald, S, Pfisterer, ME & Jeger, RV 2012, 'Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial', Journal of Internal Medicine, vol. 271, no. 3, pp. 257-263. https://doi.org/10.1111/j.1365-2796.2011.02423.x

Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial. / Burkard, T.; Kaiser, C. A.; Brunner-La Rocca, H.; Osswald, S.; Pfisterer, M. E.; Jeger, R. V.

In: Journal of Internal Medicine, Vol. 271, No. 3, 03.2012, p. 257-263.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial

AU - Burkard, T.

AU - Kaiser, C. A.

AU - Brunner-La Rocca, H.

AU - Osswald, S.

AU - Pfisterer, M. E.

AU - Jeger, R. V.

PY - 2012/3

Y1 - 2012/3

KW - antiplatelet therapy

KW - coronary artery disease

KW - myocardial infarction

KW - percutaneous coronary intervention

U2 - 10.1111/j.1365-2796.2011.02423.x

DO - 10.1111/j.1365-2796.2011.02423.x

M3 - Article

C2 - 21726302

VL - 271

SP - 257

EP - 263

JO - Journal of Internal Medicine

JF - Journal of Internal Medicine

SN - 0954-6820

IS - 3

ER -